StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories non-GAAP Adjusted Diluted Earnings Per Share ($/share) ($)

Form 8-K Quarterly Earnings Releases (Non-GAAP Reconciliation Tables)

QuarterlyAnnual
Latest, Q3 2026
1.42
Period ended Sep 30, 2026
Change on a year earlier
+9.2%
1.30 in Q3 2025
History
23 quarters
Since Q1 2021
Sources
19
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedNon-GAAP Adjusted Diluted Earnings Per Share ($/share) ($)Year on yearSource
Q3 2026Sep 30, 20261.42+9.2%SEC Filing (0001628280-26-066601) ↗
Q2 2026Jun 30, 20261.31+4.0%SEC Filing (0001628280-26-048377) ↗
Q1 2026Mar 31, 20261.15+5.5%SEC Filing (0001628280-26-025365) ↗
Q4 2025Dec 31, 20251.50+11.9%SEC Filing (0001628280-26-002982) ↗
Q3 2025Sep 30, 20251.30+7.4%SEC Filing (0001628280-26-066601) ↗
Q2 2025Jun 30, 20251.26+10.5%SEC Filing (0001628280-26-048377) ↗
Q1 2025Mar 31, 20251.09+11.2%SEC Filing (0001628280-26-025365) ↗
Q4 2024Dec 31, 20241.34+12.6%SEC Filing (0001628280-26-002982) ↗
Q3 2024Sep 30, 20241.21+6.1%SEC Filing (0001628280-25-045049) ↗
Q2 2024Jun 30, 20241.14+5.6%SEC Filing (0001628280-25-035135) ↗
Q1 2024Mar 31, 20240.98-4.9%SEC Filing (0001628280-25-017924) ↗
Q4 2023Dec 31, 20231.19+15.5%SEC Filing (0001628280-25-002092) ↗
Q3 2023Sep 30, 20231.14-0.9%SEC Filing (0001628280-24-042893) ↗
Q2 2023Jun 30, 20231.08-24.5%SEC Filing (0001628280-24-032182) ↗
Q1 2023Mar 31, 20231.03-40.5%SEC Filing (0001628280-24-016497) ↗
Q4 2022Dec 31, 20221.03-22.0%SEC Filing (0001628280-24-002009) ↗

Breakdown

What makes up non-gaap adjusted diluted earnings per share ($/share)

Cite this data

StockData. (2026). Abbott Laboratories Non-GAAP Adjusted Diluted Earnings Per Share ($/share) ($), quarterly Q1 2021–Q3 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/ng-eps-diluted

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.